Drug profile · INN
altretamine
HEXALEN
altretamine (HEXALEN) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — altretamine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
altretamine (HEXALEN) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN altretamine
Brand HEXALEN
Mechanism DNA inhibitor
Target DNA
Route ORAL
Formulation CAPSULE
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is altretamine?
altretamine (HEXALEN) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for altretamine?
HEXALEN is a marketed brand name for altretamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of altretamine?
altretamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.